At the news
? NEUTRALIMPACT 3/10 SC 13G/A filed Nov 13, 2026 at 16:04 ET
Montanova Capital LLC and affiliated entities filed an amended Schedule 13G disclosing they no longer hold any shares of Fulcrum Therapeutics as of September 30, 2026, down from a prior stake. This complete exit by a passive investment manager removes a known holder but does not signal activist intent.
- Montanova Capital, Averill Master Fund, and Aaron Cowen filed Amendment No. 3 to Schedule 13G on November 13, 2026
- The filing reports 0 shares and 0% beneficial ownership as of September 30, 2026
- The prior filing (not provided) had disclosed a non-zero stake; this amendment reflects a complete exit
- The filing states securities were held in the ordinary course and not for control purposes
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access